Will a non-contrast (without contrast) computed tomography (CT) scan detect a retroperitoneal bleed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Yes, Non-Contrast CT Will Detect Retroperitoneal Bleeding

Non-contrast CT is appropriate and effective for expeditiously confirming or excluding retroperitoneal bleeding, making it a suitable initial imaging choice when you suspect this diagnosis. 1

How Non-Contrast CT Detects Retroperitoneal Bleeds

Non-contrast CT identifies retroperitoneal hematomas based on the attenuation characteristics of blood:

  • Acute blood appears as high attenuation (hyperdense) on non-contrast imaging, typically measuring 40-70 Hounsfield units for clotted blood 2
  • Mixed attenuation patterns indicate acute-to-subacute bleeding with ongoing or recurrent hemorrhage 1
  • Low attenuation suggests subacute-to-chronic blood products 1

The speed and high spatial resolution of non-contrast CT allow it to localize the bleeding area and identify potential causes such as groin access sites, pelvic fractures, or masses 1. CT has been directly documenting retroperitoneal hemorrhage since the 1970s and provides definite diagnosis to direct appropriate therapy 3.

When Non-Contrast CT Is Particularly Appropriate

Non-contrast CT should be your first choice in these clinical scenarios:

  • Patients with compromised renal function where contrast administration is problematic 1, 4
  • When subsequent angiography may be needed and you want to minimize total contrast load 1
  • Rapid confirmation or exclusion of bleeding is the primary goal rather than identifying active extravasation 1

Important Limitations to Recognize

While non-contrast CT detects the hematoma itself, it has critical limitations:

  • Cannot identify active contrast extravasation (the "blush" sign), which requires intravenous contrast 1
  • Cannot detect the specific bleeding vessel or vascular source 1
  • Sensitivity for detecting active bleeding is only 59.5% compared to CT angiography 1, 5

The sentinel clot sign on imaging can suggest the area of bleeding even without active extravasation, but this finding is more reliably identified on contrast-enhanced studies 1.

When to Upgrade to CT Angiography

If clinical suspicion for active bleeding is high or the patient requires intervention planning, CT angiography is superior and should be performed instead:

  • CTA detects bleeding rates as low as 0.3 mL/min compared to 0.5-1.0 mL/min for conventional angiography 1
  • CTA identifies active extravasation in 78.9-84.2% of cases with active bleeding 1, 5
  • CTA provides exact hematoma location plus critical vascular information for surgical or endovascular planning 1, 4

Common Clinical Pitfall

Do not delay imaging due to renal function concerns—if contrast is truly contraindicated, proceed with non-contrast CT rather than forgoing imaging entirely, as it will still confirm or exclude the presence of retroperitoneal bleeding 1, 4. The American College of Radiology explicitly endorses non-contrast CT as appropriate for this indication 1, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Detection of retroperitoneal hemorrhage by computed tomography.

AJR. American journal of roentgenology, 1977

Guideline

Best Imaging Modality for Assessing Pelvic Hematoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.